ACTRN12616000592448Completed未知
Developmental and sequenced one to one educational intervention (DS1-EI) for autism spectrum disorder: a randomized single-blind controlled trial.
Croix Rouge Francaise0 sites70 target enrollmentStarted: May 6, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 5 Years to 9 Years (—)
- Sex
- All
Inclusion Criteria
- •Inclusion criteria :
- •- a current diagnosis of ASD confirmed by clinical assessment and the Autism Diagnostic Interview-Revised;
- •- a developmental quotient less than or equal to 24 months;
- •- no fluent oral language
- •- aged between 5 to 9 years.
- •- Controls are matched for sex, age, IQ, study sites before randomization
Exclusion Criteria
- •Exclusion criteria :
- •- parents’ refusal to participate;
- •- family project to change institution in the short term whatever the reason;
- •- patient’s agitation, hyperactivity or behavioral problems that would challenge presence in classroom.
Investigators
Similar Trials
Completed
Phase 1
SOBERANA 02Prevention of COVID-19COVID-19SARS-CoV2Disease PreventionCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000340Finlay Vaccine Institute (IFV)40
Completed
Phase 1
SOBERANA PEDIATRIACOVID-19SARS-CoV2Disease PreventionCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000374Finlay Vaccine Institute (IFV)350
Completed
Phase 1
A Phase 1, Adaptive, Single and Multiple Ascending Dose Study of EMA401 Sodium Salt Administered Orally in Healthy, Adult Males to Determine the Maximum Tolerated Dose and Pharmacokinetic ProfilesACTRN12614000802606Spinifex Pharmaceuticals Pty Ltd84
Active, not recruiting
Phase 1
Sealing pancreato-enteric anastomosis with TachoSilpancreatic surgery - evaluation of the effect of fibrin-coated collagenMedDRA version: 18.0Level: PTClassification code 10049192Term: Pancreatic fistulaSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 18.0Level: LLTClassification code 10050457Term: Pancreatic anastomotic leakSystem Organ Class: 100000004863EUCTR2013-000639-29-ATABCSG (Austrian Breast & Colorectal Cancer Study Group)
Active, not recruiting
Phase 1
A Phase I Followed by a Randomized, Phase II Study of Carboplatin and Etoposide with or without Obatoclax Administered Every 3 Weeks to Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)Extensive-Stage Small Cell Lung Cancer (ES-SCLC)MedDRA version: 9.1Level: LLTClassification code 10041068Term: Small cell lung cancer extensive stageEUCTR2008-001679-31-CZGemin X Pharmaceuticals US, Inc.